PURAPHARM (01498) Announces No Changes in Issued Shares for February 2026
Bulletin Express
Mar 05
PuraPharm Corporation Limited reported an unchanged authorized share capital of 5,000.00 billion ordinary shares at a par value of USD 0.001 each, amounting to USD 5.00 billion. As of 28 February 2026, the total issued share count remained at 535.90 million, with no treasury shares in issue.
Public float requirements were met as required by relevant regulations. Under the share option scheme, 23.96 million share options remained outstanding at the end of February 2026, and no additional new shares were issued. The documentation confirms no change in treasury shares or other agreements involving the issuance of shares during the reporting period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.